Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1998 1
1999 1
2001 1
2002 1
2003 2
2004 3
2006 1
2008 1
2011 2
2012 2
2013 2
2014 2
2015 1
2017 3
2018 5
2019 2
2020 2
2021 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
The multiple paths towards MET receptor addiction in cancer.
Duplaquet L, Kherrouche Z, Baldacci S, Jamme P, Cortot AB, Copin MC, Tulasne D. Duplaquet L, et al. Among authors: kherrouche z. Oncogene. 2018 Jun;37(24):3200-3215. doi: 10.1038/s41388-018-0185-4. Epub 2018 Mar 19. Oncogene. 2018. PMID: 29551767 Review.
When the MET receptor kicks in to resist targeted therapies.
Fernandes M, Jamme P, Cortot AB, Kherrouche Z, Tulasne D. Fernandes M, et al. Among authors: kherrouche z. Oncogene. 2021 Jun;40(24):4061-4078. doi: 10.1038/s41388-021-01835-0. Epub 2021 May 24. Oncogene. 2021. PMID: 34031544 Review.
MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)-dependent oncogenic driver in vitro and in humanised HGF knock-in mice.
Fernandes M, Hoggard B, Jamme P, Paget S, Truong MJ, Grégoire V, Vinchent A, Descarpentries C, Morabito A, Stanislovas J, Farage E, Meneboo JP, Sebda S, Bouchekioua-Bouzaghou K, Nollet M, Humez S, Perera T, Fromme P, Grumolato L, Figeac M, Copin MC, Tulasne D, Cortot AB, Kermorgant S, Kherrouche Z. Fernandes M, et al. Among authors: kherrouche z. Mol Oncol. 2023 Nov;17(11):2257-2274. doi: 10.1002/1878-0261.13397. Epub 2023 Jul 14. Mol Oncol. 2023. PMID: 36799689 Free PMC article.
Exon 14 Deleted MET Receptor as a New Biomarker and Target in Cancers.
Cortot AB, Kherrouche Z, Descarpentries C, Wislez M, Baldacci S, Furlan A, Tulasne D. Cortot AB, et al. Among authors: kherrouche z. J Natl Cancer Inst. 2017 May 1;109(5). doi: 10.1093/jnci/djw262. J Natl Cancer Inst. 2017. PMID: 28376232 Review.
MET amplification increases the metastatic spread of EGFR-mutated NSCLC.
Baldacci S, Kherrouche Z, Cockenpot V, Stoven L, Copin MC, Werkmeister E, Marchand N, Kyheng M, Tulasne D, Cortot AB. Baldacci S, et al. Among authors: kherrouche z. Lung Cancer. 2018 Nov;125:57-67. doi: 10.1016/j.lungcan.2018.09.008. Epub 2018 Sep 11. Lung Cancer. 2018. PMID: 30429039
36 results